Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule including provisions contained in H.R. 3584, the Laboratory Access for Beneficiaries (LAB) Act
Issues related to water infrastructure procurement; FY20 Interior, Environment and Related Agencies appropriations bill (H.R. 3052) and FY20 Agriculture, Rural Development, FDA, and Related Agencies appropriations bill (H.R. 3164), and provisions related to materials procurement for federal-aid projects
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs; Transit Infrastructure Vehicle Security Act (S. 846 / H.R. 2739) and provisions in FY20 National Defense Authorization Act (S. 1790 / H.R. 2500); FY20 Transportation, HUD and Related Agencies appropriations bill (H.R. 3163) and provisions related to materials procurement for federal-aid projects
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Issues related to Federal Prison Industries and DOD purchases, including FY20 National Defense Authorization Act (H.R. 2500 / S. 1790)
Issues related to Federal Prison Industries expansion efforts, including implementation of First Step Act (PL 115-391)
Duration: February 13, 2017
to
December 31, 2019
General Issues: Health Issues , Environmental/Superfund , Transportation , Trade (Domestic & Foreign) , Defense , Government Issues , Energy/Nuclear , Taxation/Internal Revenue Code
Spending: about $125,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: U.S. Senate, House of Representatives
Affiliated organizations: Laboratory Corporation of America Holdings; ArcelorMittal USA; Alliance for American Manufacturing; Specialty Steel Industry of North America
Related Foreign Entities:
ArcelorMittal (Luxembourg, LUX); contribution to lobbying: $0; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2019
Mrs. Maggie Crosswy terminated an engagement in which they represented Kelley Drye & Warren LLP on Jan. 17, 2020.
Original Filing: 301109155.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule including provisions contained in H.R. 3584, the Laboratory Access for Beneficiaries (LAB) Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; FY20 Interior, Environment and Related Agencies appropriations bill (H.R. 3052) and FY20 Agriculture, Rural Development, FDA, and Related Agencies appropriations bill (H.R. 3164), and provisions related to materials procurement for federal-aid projects
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs; Transit Infrastructure Vehicle Security Act (S. 846 / H.R. 2739) and provisions in FY20 National Defense Authorization Act (S. 1790 / H.R. 2500); FY20 Transportation, HUD and Related Agencies appropriations bill (H.R. 3163) and provisions related to materials procurement for federal-aid projects
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to Federal Prison Industries and DOD purchases, including FY20 National Defense Authorization Act (H.R. 2500 / S. 1790)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Federal Prison Industries expansion efforts, including implementation of First Step Act (PL 115-391)
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $10,000. The report was filed on Oct. 21, 2019.
Original Filing: 301079184.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule including provisions contained in H.R. 3584, the Laboratory Access for Beneficiaries (LAB) Act; federal policy and draft legislation relating to subject matter eligibility for patents of laboratory tests
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; FY20 Interior, Environment and Related Agencies appropriations bill (H.R. 3052) and FY20 Agriculture, Rural Development, FDA, and Related Agencies appropriations bill (H.R. 3164), and provisions related to materials procurement for federal-aid projects
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs; Transit Infrastructure Vehicle Security Act (S. 846 / H.R. 2739) and provisions in FY20 National Defense Authorization Act (S. 1790 / H.R. 2500); FY20 Transportation, HUD and Related Agencies appropriations bill (H.R. 3163) and provisions related to materials procurement for federal-aid projects
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to Federal Prison Industries and DOD purchases, including FY20 National Defense Authorization Act (H.R. 2500 / S. 1790)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Federal Prison Industries expansion efforts, including implementation of First Step Act (PL 115-391)
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $10,000. The report was filed on July 22, 2019.
Original Filing: 301054185.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule including provisions contained in H.R. 3584, the Laboratory Access for Beneficiaries (LAB) Act; federal policy and draft legislation relating to subject matter eligibility for patents of laboratory tests
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; FY20 Interior, Environment and Related Agencies appropriations bill (H.R. 3052) and FY20 Agriculture, Rural Development, FDA, and Related Agencies appropriations bill (H.R. 3164), and provisions related to materials procurement for federal-aid projects
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs; Transit Infrastructure Vehicle Security Act (S. 846 / H.R. 2739); FY20 Transportation, HUD and Related Agencies appropriations bill (H.R. 3163) and provisions related to materials procurement for federal-aid projects
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to Federal Prison Industries expansion efforts, including FY20 National Defense Authorization Act (H.R. 2500 / S. 1790)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Federal Prison Industries expansion efforts, including implementation of First Step Act (PL 115-391)
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $10,000. The report was filed on April 19, 2019.
Original Filing: 301030545.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA), FDA's technical assistance on DAIA, and discussion draft of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; FY19 omnibus appropriations bill (H.J.Res. 31) and provisions related to materials procurement for federal-aid projects
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2018
In Q4, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $5,000. The report was filed on Jan. 22, 2019.
Original Filing: 301017216.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA), FDA's technical assistance on DAIA, and discussion draft of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; FY19 Interior / Environment appropriations bills (H.R. 6147 / S. 3073) and provisions related to materials procurement for federal-aid projects; S. 3021 / S. 2800, America's Water Infrastructure Act of 2018 / H.R. 8, Water Resources Development Act of 2018
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2018
In Q3, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $5,000. The report was filed on Oct. 22, 2018.
Original Filing: 300998109.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA); Medicare reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; FY19 Interior / Environment appropriations bills (H.R. 6147 / S. 3073) and provisions related to materials procurement for federal-aid projects; S. 3021 / S. 2800, America's Water Infrastructure Act of 2018 / H.R. 8, Water Resources Development Act of 2018
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2018
In Q2, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $5,000. The report was filed on July 20, 2018.
Original Filing: 300975268.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA); Medicare reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; FY19 Interior / Environment appropriations bills (H.R. 6147 / S. 3073) and provisions related to materials procurement for federal-aid projects; S. 2800, America's Water Infrastructure Act of 2018 / H.R. 8, Water Resources Development Act of 2018
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2018
In Q1, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $10,000. The report was filed on April 20, 2018.
Original Filing: 300953914.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA); Medicare reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule; TRICARE coverage of laboratory tests
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; FY18 omnibus appropriations bill and provisions related to materials procurement for federal-aid projects; H.R. 3387, Drinking Water System Improvement Act of 2017
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2017
In Q4, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $5,000. The report was filed on Jan. 22, 2018.
Original Filing: 300936475.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including the discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA); Medicare reimbursement levels for laboratory services and reforms to the Clinical Lab Fee schedule; TRICARE coverage of laboratory tests
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; H.R. 3354, FY18 Interior / EPA appropriations bill; H.R. 3387, Drinking Water System Improvement Act of 2017
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2017
In Q3, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $20,000. The report was filed on Oct. 20, 2017.
Original Filing: 300916843.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including the discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA); Medicare reimbursement levels for laboratory services and reforms to the Clinical Lab Fee schedule; TRICARE coverage of laboratory tests
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure procurement; H.R. 3354, FY18 Interior / EPA appropriations bill; H.R. 3387, Drinking Water System Improvement Act of 2017
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2017
In Q2, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $20,000. The report was filed on July 20, 2017.
Original Filing: 300896660.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including the discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA); Medicare reimbursement levels for laboratory services and reforms to the Clinical Lab Fee schedule; TRICARE coverage of laboratory tests
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to water infrastructure and procurement; draft FY18 Interior / EPA appropriations bill; draft Drinking Water System Improvement Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to transportation infrastructure and procurement
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2017
In Q1, Mrs. Maggie Crosswy lobbied for Kelley Drye & Warren LLP , earning $20,000. The report was filed on April 20, 2017.
Original Filing: 300878293.xml
Lobbying Issues
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests; Medicare reimbursement levels for laboratory developed tests and reforms to the Clinical Lab Fee schedule; TRICARE coverage of laboratory developed tests
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal trade policy as it relates to unfair trade practices and trade law enforcement
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to transportation infrastructure and procurement
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
Mrs. Maggie Crosswy filed a lobbying registration on April 4, 2017 to represent Kelley Drye & Warren LLP, effective Feb. 13, 2017.
Original Filing: 300862517.xml
Issue(s) they said they’d lobby about: Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests; Medicare reimbursement levels for laboratory services; General environmental issues affecting steel production; Any and all energy issues, as they pertain to the steel industry; General trade legislation, as it relates to unfair trade practices and trade law enforcement; Issues related to corporate tax reform; Issues related to transportation infrastructure .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...